DrugDashboards

doxorubicin hydrochloride

doxorubicin hydrochloride · DOXORUBICIN HYDROCHLORIDE 2 mg/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals

NDC 25021-0207-25 · 1 VIAL in 1 CARTON / 25 mL in 1 VIAL · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$24.50
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$2.710
HCPCS J9000 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$17,247
504 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA209825
TE code
AP
Approval date
Aug 11, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of doxorubicin hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Gland Pharma LimitedDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Pfizer Laboratories Div Pfizer IncDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Sun Pharmaceutical Industries, Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Fresenius Kabi USA, LLCDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "doxorubicin hydrochloride — NDC 25021-0207-25," retrieved September 3, 2026, https://drugdashboards.com/drug/25021020725.

Free to cite with attribution — see how the data is put together.